The economic burden of constipation therapy.
constipation
drug
health economics
pharmaeconomics
Journal
Medicine and pharmacy reports
ISSN: 2668-0572
Titre abrégé: Med Pharm Rep
Pays: Romania
ID NLM: 101742144
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
29
10
2018
revised:
28
12
2018
accepted:
17
01
2019
entrez:
29
8
2019
pubmed:
29
8
2019
medline:
29
8
2019
Statut:
ppublish
Résumé
Constipation is a widespread condition that requires adequate therapy. Given the large use of laxatives, it is important to know the burden of the treatment of this condition on the healthcare budget. We collected information on the number of therapeutic units (boxes) of five frequently used laxatives delivered by prescription or over the counter in 30 pharmacies randomly selected in two adjacent counties from Romania for two consecutive years. We calculated also the cost value of the laxatives delivered. The total cost of laxatives in the group of pharmacies investigated was on average 62,500 euros per year. We extrapolated that the laxative consumption in Romania should be over 15 million Euro. To our knowledge this is the first study on the burden of constipation in this country. Although therapeutic units of laxatives are not expensive, the wide use of these drugs represents an economic burden for the patient.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
Constipation is a widespread condition that requires adequate therapy. Given the large use of laxatives, it is important to know the burden of the treatment of this condition on the healthcare budget.
METHODS
METHODS
We collected information on the number of therapeutic units (boxes) of five frequently used laxatives delivered by prescription or over the counter in 30 pharmacies randomly selected in two adjacent counties from Romania for two consecutive years. We calculated also the cost value of the laxatives delivered.
RESULTS
RESULTS
The total cost of laxatives in the group of pharmacies investigated was on average 62,500 euros per year. We extrapolated that the laxative consumption in Romania should be over 15 million Euro.
CONCLUSIONS
CONCLUSIONS
To our knowledge this is the first study on the burden of constipation in this country. Although therapeutic units of laxatives are not expensive, the wide use of these drugs represents an economic burden for the patient.
Identifiants
pubmed: 31460507
doi: 10.15386/mpr-1222
pii: cm-92-261
pmc: PMC6709959
doi:
Types de publication
Journal Article
Langues
eng
Pagination
261-264Références
Rom J Intern Med. 1998 Jul-Dec;36(3-4):239-43
pubmed: 10822520
Pharmacoeconomics. 2005;23(5):461-76
pubmed: 15896098
Aliment Pharmacol Ther. 2007 Jul 15;26(2):237-48
pubmed: 17593069
J Am Board Fam Med. 2011 Jul-Aug;24(4):436-51
pubmed: 21737769
Can J Gastroenterol. 2011 Oct;25 Suppl B:11B-15B
pubmed: 22114752
Am J Gastroenterol. 2014 Feb;109(2):250-6
pubmed: 24419480
J Med Econ. 2014 Aug;17(8):577-86
pubmed: 24811855
Clinicoecon Outcomes Res. 2014 Aug 12;6:369-79
pubmed: 25143749
Am J Gastroenterol. 2015 Apr;110(4):572-9
pubmed: 25803399
J Gastrointestin Liver Dis. 2015 Dec;24(4):539-40
pubmed: 26697587
Curr Opin Pharmacol. 2017 Dec;37:158-166
pubmed: 29172123
Pharmacoeconomics. 2018 Apr;36(4):435-449
pubmed: 29352437
Medicine (Baltimore). 2018 May;97(20):e10631
pubmed: 29768326
Scand J Gastroenterol. 1997 Sep;32(9):920-4
pubmed: 9299672